Latest Retinal gene therapy using lentiviral vectors Stories
GREENWICH, Conn., Aug.
In what represents an important step toward curing HIV, a USC scientist has created a virus that hunts down HIV-infected cells.
Give caffeine to cells engineered to produce viruses used for gene therapy and the cells can generate 3- to 8-times more virus.
GAITHERSBURG, Md., Nov. 3, 2010 /PRNewswire/ -- Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that it will receive $1,235,306 in cash grants from the U.S.
Novel therapy for blindness works only when specific gene mutation present.
GAITHERSBURG, Md,, Dec.
US researchers said on Wednesday that a year after receiving gene therapy for a condition that causes total blindness by age 30, three people continue to see better and one has improved enough to read the digital numbers on a clock.
Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy.
Vectors derived from retroviruses are useful tools for long-term gene transfer because they allow stable integration of transgenes and propagation into daughter cells.
Gene therapy is the introduction of genetic material into a patient's cells resulting in a cure or a therapeutic effect.